Screener
Haemonetics HAE Common stock, par value (in dollars per share)
Common stock, par value (in dollars per share) at other companies
Other financials
Where this comes from
Reported directly by Haemonetics in its filing.
Tagged under the XBRL concept us-gaap:CommonStockParOrStatedValuePerShare.
The source filing: Haemonetics’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 6:09 AM EDT
- Fiscal quarter
- Q1 FY2027
- Calendar quarter
- Q2 2026
- Accession
- 0000313143-26-000120
| Line item | June 27, 2026 | March 28, 2026 |
|---|---|---|
| Deferred tax liability | 38,691 | 38,048 |
| Other long-term liabilities | 57,171 | 59,393 |
| Stockholders’ equity: | ||
| Common stock, $0.01 par value; Authorized — 150,000,000 shares; Issued and outstanding — 45,471,313 shares as of June 27, 2026 and 45,252,667 shares as of March 28, 2026 | 455 | 453 |
| Additional paid-in capital | 566,759 | 554,137 |
| Retained earnings | 311,516 | 279,344 |
| Accumulated other comprehensive loss | (41,629) | (37,614) |
| Total stockholders’ equity | 837,101 | 796,320 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Haemonetics's common stock, par value (in dollars per share)?
- Haemonetics (HAE) reported common stock, par value (in dollars per share) of $0.01 in Q2 2026.
- How has Haemonetics's common stock, par value (in dollars per share) changed year-over-year?
- Haemonetics's common stock, par value (in dollars per share) decreased by 0.0% year-over-year, from $0.01 to $0.01.
- What is the long-term trend for Haemonetics's common stock, par value (in dollars per share)?
- Over 5 years (2021 to 2026), Haemonetics's common stock, par value (in dollars per share) has grown at a 0.0% compound annual growth rate (CAGR), from $0.01 to $0.01.
- What does common stock, par value (in dollars per share) mean?
- Common stock, par value (in dollars per share)
Ask your AI about Haemonetics's common stock, par value (in dollars per share).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude